Highlights

Read More

Regenity Biosciences receives strategic investment from Cinven, adding new partner alongside Linden Capital Partners

Transaction will establish partnership between Regenity, Cinven, and legacy investor Linden Capital…

Read More
Read More

Regenity Biosciences to Exhibit at MD&M West 2026

At MD&M West 2026, Regenity will share how its integrated contract development and manufacturing…

Read More
Read More

Regenity Demonstrates Next-Generation Regenerative Technologies at MEDICA 2025

At MEDICA 2025, Regenity will showcase how its global CDM business model supports the design,…

Read More
Read More

Regenity Redefines Medical Device Innovation Via Advanced Contract Development and Manufacturing Expertise, Honored with Prestigious 2025 R&D 100 Award

Regenity Biosciences has been recognized as a winner of the 2025 R&D 100 Awards for its…

Read More
Read More

Regenity Expands Global Footprint with NMPA Approval in China

Milestone Marks Another Dental Product Approval in China’s Fast-Growing Regenerative Sector

Read More
Read More

Regenity Biosciences Completes First Surgery with RejuvaKnee™, Pioneering Meniscal Repair Innovation

Regenity Biosciences, a global leader in regenerative medicine and Linden Capital Partners…

Read More

Let’s Connect

Looking for a reliable partner to fill your product portfolio gap, co-create your next great innovation or manufacture your products?